Cristina Mussini
Cristina Mussini
Professor of Infectious Diseases, Univ. of Modena and Reggio Emilia
Verifierad e-postadress på unimore.it
Titel
Citeras av
Citeras av
År
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20062003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
13912006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10402008
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
G Ferrara, M Losi, R D'Amico, P Roversi, R Piro, M Meacci, B Meccugni, ...
The Lancet 367 (9519), 1328-1334, 2006
6932006
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ...
The Lancet Rheumatology 2 (8), e474-e484, 2020
6212020
Common genetic variation and the control of HIV-1 in humans
J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ...
PLoS genetics 5 (12), e1000791, 2009
4112009
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
4062019
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3822004
Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease
G Monti, M Galli, F Invernizzi, P Pioltelli, F Saccardo, A Monteverde, ...
QJM: An International Journal of Medicine 88 (2), 115-126, 1995
3361995
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2592005
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort …
Collaboration of Observational HIV Epidemiological Research Europe (COHERE ...
International journal of epidemiology 41 (2), 433-445, 2012
2552012
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
S De Biasi, M Meschiari, L Gibellini, C Bellinazzi, R Borella, L Fidanza, ...
Nature communications 11 (1), 1-17, 2020
2542020
Response to combination antiretroviral therapy: variation by age
Collaboration of Observational HIV Epidemiological Research Europe (COHERE ...
Aids 22 (12), 1463-1473, 2008
2512008
Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy
K Bhaskaran, C Mussini, A Antinori, AS Walker, M Dorrucci, C Sabin, ...
Annals of neurology 63 (2), 213-221, 2008
2292008
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects
M Airoldi, M Zaccarelli, L Bisi, T Bini, A Antinori, C Mussini, F Bai, ...
Patient preference and adherence 4, 115, 2010
2282010
Combination therapy for carbapenem-resistant Gram-negative bacteria
M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ...
Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014
2202014
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
C Mussini, P Lorenzini, A Cozzi-Lepri, G Lapadula, G Marchetti, E Nicastri, ...
The lancet HIV 2 (3), e98-e106, 2015
2012015
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
1972019
Performance of tests for latent tuberculosis in different groups of immunocompromised patients
L Richeldi, M Losi, R D'Amico, M Luppi, A Ferrari, C Mussini, M Codeluppi, ...
Chest 136 (1), 198-204, 2009
1962009
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ...
The Lancet infectious diseases 16 (5), 565-575, 2016
1932016
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20